Full service translation and interpreting company, TRANSLIT, has secured half a million euro in funding through private equity firm, Clashrock Capital.
Headquartered in Cork, with offices in Dublin and Limerick, TRANSLIT has an impressive portfolio of national and international public and private sector clients. The company, which employs translators and interpreters all around the world, has significant expansion plans, which include a new technology platform, to provide best-in-class translation and interpreting services on-demand.
This investment will see Dave Ronayne, Mainport Group and Frankie Whelehan, Chesway Group working closely with the TRANSLIT management team, led by CEO Alex Chernenko.
“We were attracted to invest in TRANSLIT having recognised their extensive international portfolio of clients, an exceptional network of international interpreters and translators, and proven leadership of CEO Alex Chernenko for the last 9 years,” said Martin Fitzgerald, Clashrock Capital.
“With this investment, and experience and vision of the Clashrock’s backers, we see huge market opportunity for this established and proven player to dominate the international language services market.”
In Ireland, TRANSLIT provides services for leading corporates from Johnson & Johnson to Allergan, as well as the Department of Foreign Affairs, Bord Bia, HSE and Legal Aid Board among others. International clients include KPMG, American Express, China’s Chemical Inspection & Regulation Service, Japan’s leading telco IIJ, Avara Pharmaceuticals and Novartis among others.
Apart from translation and interpreting, TRANSLIT provides a wide range of language services such as website localisation, document legalisation and voiceover.
Последние публикации в категории
- Number of Irish passport applications rises to record level
- Motorists are being warned that the Gardai will be out in force targeting drivers under the influence of drink and drugs over the St Patrick’s Weekend
- Orange and Yellow Weather Warnings for Storm Gareth
- Bus Accident Claims *